| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 3,1 M € | +19.6% | 2,6 M € | +8.5% | 2,4 M € | -0.8% | 2,4 M € | -11.5% | 2,8 M € | +45.4% | 1,9 M € | -21.4% | 2,4 M € | +27.5% | 1,9 M € | +5.2% | 1,8 M € | +24.3% | 1,4 M € | +5.4% | 1,4 M € | +6.7% | 1,3 M € | +11.5% | 1,2 M € | +43.6% | 802,2 k € | +3.0% | 779,1 k € | +12.1% | 695,2 k € | +13.9% | 610,2 k € | +11.6% | 546,9 k € | +45.2% | 376,7 k € | |
| EBITDA | 790,8 k € | +72.4% | 458,6 k € | +3.1% | 444,6 k € | -3.4% | 460,2 k € | -58.9% | 1,1 M € | +204.3% | 368,3 k € | -61.4% | 954,3 k € | +63.2% | 584,8 k € | -2.4% | 599,2 k € | +84.1% | 325,6 k € | +35.8% | 239,7 k € | -20.7% | 302,3 k € | -7.9% | 328,1 k € | +52.4% | 215,3 k € | -29.9% | 307,2 k € | +12.8% | 272,4 k € | +23.8% | 220,0 k € | -21.1% | 278,6 k € | +110.5% | 132,4 k € | |
| Operating profit | 477,0 k € | +260.4% | 132,3 k € | -15.7% | 156,9 k € | -33.7% | 236,5 k € | -74.4% | 922,4 k € | +334.4% | 212,4 k € | -73.6% | 805,4 k € | +83.7% | 438,6 k € | -2.7% | 450,5 k € | +116.8% | 207,8 k € | +75.4% | 118,4 k € | -34.9% | 182,0 k € | -25.0% | 242,8 k € | +57.6% | 154,0 k € | -31.9% | 226,0 k € | +17.9% | 191,6 k € | +1.1% | 189,5 k € | -20.3% | 237,7 k € | +128.2% | 104,2 k € | |
| Profit/loss | 303,8 k € | +348.2% | 67,8 k € | -32.6% | 100,5 k € | -39.3% | 165,5 k € | -76.6% | 706,1 k € | +474.4% | 122,9 k € | -77.8% | 555,0 k € | +98.0% | 280,3 k € | -0.4% | 281,4 k € | +150.0% | 112,5 k € | +122.2% | 50,6 k € | -48.7% | 98,8 k € | -43.0% | 173,2 k € | +42.2% | 121,8 k € | -27.2% | 167,2 k € | +11.5% | 150,0 k € | -2.1% | 153,1 k € | -11.0% | 172,1 k € | +57.1% | 109,5 k € | |
| Equity | 3,4 M € | +6.3% | 3,2 M € | -1.0% | 3,3 M € | +0.0% | 3,3 M € | +2.0% | 3,2 M € | +28.1% | 2,5 M € | +5.0% | 2,4 M € | +30.1% | 1,8 M € | +18.6% | 1,5 M € | +22.2% | 1,3 M € | +9.8% | 1,2 M € | +4.6% | 1,1 M € | +9.8% | 1,0 M € | +20.8% | 830,9 k € | +17.2% | 709,2 k € | +21.8% | 582,0 k € | +10.2% | 528,0 k € | +28.5% | 410,9 k € | +68.2% | 244,3 k € | |
| Total assets | 5,7 M € | +15.7% | 4,9 M € | -7.9% | 5,3 M € | +16.2% | 4,6 M € | +6.1% | 4,3 M € | +23.3% | 3,5 M € | +12.9% | 3,1 M € | +1.2% | 3,1 M € | +18.1% | 2,6 M € | +6.7% | 2,4 M € | +4.3% | 2,3 M € | -3.5% | 2,4 M € | +6.5% | 2,3 M € | +11.9% | 2,0 M € | +19.4% | 1,7 M € | -0.3% | 1,7 M € | +22.8% | 1,4 M € | +48.4% | 931,6 k € | +37.2% | 679,2 k € | |
| Cash | 344,7 k € | -59.3% | 847,8 k € | -1.6% | 861,9 k € | +10.9% | 777,2 k € | +13.7% | 683,5 k € | -5.0% | 719,6 k € | +6.6% | 675,3 k € | -19.8% | 842,3 k € | +66.3% | 506,4 k € | +12.5% | 450,0 k € | +79.0% | 251,4 k € | -34.4% | 383,1 k € | +7.8% | 355,2 k € | +90.3% | 186,7 k € | -9.7% | 206,8 k € | +51.5% | 136,5 k € | -67.9% | 425,5 k € | +321.8% | 100,9 k € | -8.9% | 110,7 k € | |
| Debts | 2,2 M € | +33.9% | 1,6 M € | -18.1% | 2,0 M € | +53.0% | 1,3 M € | +18.1% | 1,1 M € | +10.9% | 986,0 k € | +39.7% | 706,0 k € | -42.0% | 1,2 M € | +17.0% | 1,0 M € | -10.3% | 1,2 M € | -1.0% | 1,2 M € | -10.3% | 1,3 M € | +6.5% | 1,2 M € | +10.3% | 1,1 M € | +15.4% | 963,4 k € | +5.4% | 913,8 k € | +7.0% | 854,3 k € | +64.1% | 520,7 k € | +19.7% | 434,9 k € | |
| Staff | 37,3 | 36,3 | 34,5 | 35,6 | 32,3 | 28,7 | 29 | 28,3 | 26,1 | 23,8 | 23,9 | 22,3 | 23,2 | 16,8 | 16,2 | 14,2 | 13,1 | 11 | 10,4 | |||||||||||||||||||
Private limited company · Liège · incorporated on 19/11/1986 · 37,3 ETP
Private limited company profitable and well capitalised. Cash position declining (-59.3%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MEDIPOST is a Private limited company incorporated in 1986. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Liège. It employs on average 37,3 ETP workers (FTE).
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette